Globus Medical, Inc. shines with strong Q4 results & Nevro acquisition, boosting its market position. Click here to find out ...

Learn more about whether Globus Medical, Inc. or LeMaitre Vascular, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Globus Medical currently trades at $75.69 per share and has shown little upside over the past six months, posting a middling ...

In the assessment of 12-month price targets, analysts unveil insights for Globus Medical, presenting an average target of $90 ...

Globus Medical is gearing up for a series of product launches throughout the Musculoskeletal portfolio in the coming months of 2025.

With this system, an A is better than a B ... the better. Audubon, PA-based Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients ...

Globus Medical has completed its acquisition ... Nevro's HFX spinal cord stimulation platform (SCS) includes the Senza SCS system. It offers support services for chronic pain treatment of limbs ...

Detailed price information for Globus Medical Inc (GMED-N) from The Globe and Mail including charting and trades.